View Press Releases
-
Alfa Chemistry Integrates Its Supply of Boronic Compounds for the Science Community
RONKONKOMA, NY, UNITED STATES - Apr 23, 2020 - The world's leading chemical supplier Alfa Chemistry announced to have integrated its supply of boronic compound products to its customers worldwide, which include borate, boro-amino acids, boronic acids, boronic esters as well as others
Apr 28, 2020
-
AI & Medicine Releases Solutions for ADMET Prediction for Pharmaceutical Industry
NY, NY, UNITED STATES - Apr 28, 2020 - AI & Medicine, a company that provides a unique artificial intelligence (AI) drug research and development platform, announced that it offers solutions and expertise on ADMET prediction for pharmaceutical enterprises and medical institutions across the globe
Apr 28, 2020
-
Visbion Image Cubes deployed at NHS Nightingale Hospitals across the UK
CHERTSEY, SURREY, UK - Apr 28, 2020 - As part of the NHS emergency response to Covid-19, Visbions Image Cube has been deployed at the new NHS Nightingale Hospitals in London, Birmingham and Harrogate
Apr 28, 2020
-
BOC Sciences Provides Raw Materials for COVID-19 Test Kits
SHIRLEY, NY - Apr 28, 2020 - On April 27, 2020, BOC Sciences, a well-known pharmaceutical raw material supplier, announced its commitment to provide customers with the raw materials needed for the manufacture of COVID-19 test kits to meet the challenges facing the global pharmaceutical industry
Apr 27, 2020
-
Tjoapack receives investment from Ampersand Capital Partners
ETTEN-LEUR, NETHERLANDS - Apr 27, 2020 - Tjoapack Netherlands B.V., a global contract packaging organisation (CPO) for the pharmaceutical industry, today announced a majority investment from Ampersand Capital Partners, a private equity firm that specialises in partnering with entrepreneur-led healthcare companies
Apr 27, 2020
-
Creative Biolabs Releases One-stop HLA Typing and KIR Typing Services
NEW YORK, NY, UNITED STATES - Apr 27, 2020 - The chimeric antigen receptor T (CAR-T) cell immunotherapy covers a wide range of diseases, including acute leukemia, non-Hodgkin's lymphoma, and even tumors, autoimmune diseases, HIV, heart disease, etc
Apr 26, 2020
-
Companies Launch New Framework to Accelerate COVID-19 Research; Streamlines Path for Diagnostics, Monitoring and Clinical Trials
PALO ALTO, CA, UNITED STATES - Apr 23, 2020 - Companies Launch New Framework to Accelerate COVID-19 Research; Streamlines Path for Diagnostics, Monitoring and Clinical TrialsMedable Inc
Apr 23, 2020
-
Imvax Appoints Mark Exley, Ph.D. as Chief Scientific Officer
PHILADELPHIA, PA, UNITED STATES - Apr 23, 2020 - Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO)
Apr 23, 2020
-
TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief
NORTH READING, MA, UNITED STATES - Apr 22, 2020 - NORTH READING, MASS. (April 16, 2020) -TraceLink Inc., the leading digital platform company for the life sciences industry, today announced a new package of agile solutions designed to digitalize the pharmaceutical supply chain
Apr 22, 2020
-
AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases
RESEARCH TRIANGLE PARK, NC, US - Apr 22, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research (INSERM) spin-out with expertise and an intellectual property estate for the treatment of neurodegenerative disorders
Apr 22, 2020
-
Creative Biolabs Released Modotuximab for Research Use
SHIRLEY, NY - Apr 22, 2020 - April 22, 2020, Creative Biolabs, as a leading supplier in recombinant antibody discovery and manufacturing, is equipped with cutting-edge hybridoma development and phage display platforms to be able to offer customers with high-quality and professional services
Apr 21, 2020
-
InSysBio innovates its Immune Response Template Database
MOSCOW, RUSSIA - Apr 15, 2020 - InSysBio is one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling has published the new version of IRT database, one of its core products
Apr 21, 2020
-
Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites
PRESTON, UNITED KINGDOM - Apr 20, 2020 -
- Panthera's second clinical trial site in the UK, in North Manchester is open for business.
- As a standalone site ideal for existing or new trials with much lower contamination risk during COVID-19
-
Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development
BOURNEMOUTH, UK - Apr 20, 2020 - Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS single cell cloning instrument
Apr 20, 2020
-
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
LONDON, UNITED KINGDOM - Apr 20, 2020 - MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels
Apr 20, 2020
-
MDI Biological Laboratory Names New Faculty Member
BAR HARBOR, ME, UNITED STATES - Apr 17, 2020 - The MDI Biological Laboratory has announced that Prayag Murawala, Ph.D., has joined the faculty as an assistant professor
Apr 17, 2020
-
MDI Biological Laboratory-led Program Reveals High Arsenic in Well Water
BAR HARBOR, ME, UNITED STATES - Apr 16, 2020 - A program to teach data literacy to Maine and New Hampshire students by analyzing data on arsenic in well water collected from their homes has found that 25 percent of samples exceed the New Hampshire maximum safety level of 5 parts per billion (ppb) and 15 percent exceed the U
Apr 16, 2020
-
EPS Corporation Signs Groundbreaking Agreement to Drive Increased Quality and Safety Using CluePoints Risk-Based Quality Management Solution
KING OF PRUSSIA, PA, US - Apr 16, 2020 - King of Prussia, PA - April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a cost-effective and resource-efficient manner
Apr 16, 2020
-
Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines
COLMAR, PA - Apr 15, 2020 - Biological Specialty Company (BSC) has launched an at-home blood donation service for COVID-19 positive patients
Apr 15, 2020
-
Volunteer laboratory network launched to expand Covid-19 testing for key workers
OXFORD, UNITED KINGDOM - Apr 15, 2020 -
- The UK urgently needs to expand Covid-19 testing capacity for front-line healthcare workers
- There are thousands of laboratories in the UK with the right equipment and expertise to run these tests - but they are currently not being used
- SBL, a medical research laboratory in Oxfordshire, is already running 250-500 tests a week for local GPs, with same-day results
- This project, launched and funded to £1M by Mike Fischer CBE, aims to build an emergency volunteer network of laboratories willing to convert to Covid-19 testing, to supplement the Government's existing facilities
- A national network could deliver tens of thousands of additional tests per day